Fibrosis and cardiac arrhythmias

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 6, 2011, Pages 630-638

  De Jong, Sanne ^a   Van Veen, Toon A B ^a   Van Rijen, Harold V M ^a   De Bakker, Jacques M T ^a,b,c,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Heart Failure Research Center   (Netherlands)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

arrhythmias; collagen; electrophysiology; fibrosis

Indexed keywords

COLLAGEN; CONNEXIN 43; SODIUM CHANNEL; TRANSFORMING GROWTH FACTOR BETA;

AGING; CARDIAC CHANNELOPATHY; CELL FRACTIONATION; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; ELECTROCHEMOTHERAPY; ELECTROGRAPHY; FIBROBLAST; HEART ARRHYTHMIA; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART VENTRICLE TACHYCARDIA; HUMAN; IMMUNOHISTOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFRACTORY PERIOD; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR;

AGING; ANIMALS; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CHANNELOPATHIES; EARLY DIAGNOSIS; ENDOMYOCARDIAL FIBROSIS; FIBROSIS; HEART ATRIA; HUMANS; MAGNETIC RESONANCE IMAGING; TACHYCARDIA, VENTRICULAR;

EID: 79958259758     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318207a35f     Document Type: Review

References (78)

1. Icardo JM, Colvee E. Collagenous skeleton of the human mitral papillary muscle.Anat Rec. 1998;252:509-518. (Pubitemid 28533399)
2. Manasek FJ. Macromolecules of the extracellular compartment of embryonic and mature hearts. Circ Res. 1976;38:331-337.
3. Weber KT, Sun Y, Tyagi SC, et al. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol. 1994;26:279-292. (Pubitemid 24199288)
4. Severs NJ, Bruce AF, Dupont E, et al. Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res. 2008;80: 9-19.
5. Nattel S, Maguy A, Le Bouter S, et al. Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev. 2007;87:425-456. (Pubitemid 47084677)
6. Laurent GJ. Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am J Physiol. 1987;252:C1-C9.
7. Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J. 1986;55:575-581. (Pubitemid 16092908)
8. De Souza RR. Aging of myocardial collagen. Biogerontology. 2002;3: 325-335.
9. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol. 1992;262:H1861-H1866.
10. Gilbert KC, Brown NJ. Aldosterone and inflammation. Curr Opin Endocrinol Diabetes Obes. 2010;17:199-204.
11. Lijnen PJ, Petrov VV, Fagard RH. Induction of cardiac fibrosis by transforming growth factor-beta(1). Mol Genet Metab. 2000;71:418-435.
12. Osadchii OE. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev. 2007;12:66-86. (Pubitemid 46629248)
13. Stein M, Noorman M, van Veen TA, et al. Dominant arrhythmia vulnerability of the right ventricle in senescent mice. Heart Rhythm. 2008; 5:438-448.
14. Klima M, Burns TR, Chopra A. Myocardial fibrosis in the elderly. Arch Pathol Lab Med. 1990;114:938-942.
15. Spach MS, Miller WT 3rd, Dolber PC, et al. The functional role of structural complexities in the propagation of depolarization in the atrium of the dog. Cardiac conduction disturbances due to discontinuities of effective axial resistivity. Circ Res. 1982;50:175-191. (Pubitemid 12168310)
16. Van Rijen HV, Eckardt D, Degen J, et al. Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation. 2004;109: 1048-1055. (Pubitemid 38282860)
17. Van Veen TA, Stein M, Royer A, et al. Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation. 2005; 112:1927-1935. (Pubitemid 41377410)
18. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262. (Pubitemid 29056953)
19. Kawara T, Derksen R, de Groot JR, et al. Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation. 2001;104:3069-3075. (Pubitemid 34014059)
20. Suk T, Edwards C, Hart H, et al. Myocardial scar detected by contrastenhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients. Heart Lung Circ. 2008;17:370-374.
21. De Bakker JM, van Capelle FJ, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation. 1988;77: 589-606. (Pubitemid 18073351)
22. De Bakker JM, van Capelle FJ, Janse MJ, et al. Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation. 1993; 88:915-926. (Pubitemid 23264006)
23. Ten Tusscher KH, Panfilov AV. Influence of diffuse fibrosis on wave propagation in human ventricular tissue. Europace. 2007;9(Suppl 6): vi38-vi45.
24. Gardner PI, Ursell PC, Fenoglio JJ Jr, et al. Electrophysiologic and anatomic basis for fractionated electrograms recorded from healed myocardial infarcts. Circulation. 1985;77:596-611. (Pubitemid 15242254)
25. Anderson KP,Walker R, Urie P, et al. Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. J Clin Invest. 1993;92: 122-140. (Pubitemid 23208988)
26. Li D, Fareh S, Leung TK, et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999; 100:87-95. (Pubitemid 29297945)
27. Lammers WJEP, Schalij MJ, Kirchhof CJHJ, et al. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol. 1990;259:H1254-H1263. (Pubitemid 20352329)
28. Shiroshita-Takeshita A, Sakabe M, Haugan K, et al. Model-dependent effects of the gap junction conduction-enhancing antiarrhythmic peptide rotigaptide (ZP123) on experimental atrial fibrillation in dogs. Circulation. 2007;115:310-318. (Pubitemid 46151658)
29. Xing D, Kjølbye AL, Nielsen MS, et al. ZP123 increases gap junctional conductance and prevents reentrant ventricular tachycardia during myocardial ischemia in open chest dogs. J Cardiovasc Electrophysiol. 2003;14:510-520. (Pubitemid 36583913)
30. Wiegerinck RF, de Bakker JM, Opthof T, et al. The effect of enhanced gap junctional conductance on ventricular conduction in explanted hearts from patients with heart failure. Basic Res Cardiol. 2009;104:321-332.
31. Kojodjojo P, Kanagaratnam P, Segal OR, et al. The effects of carbenoxolone on human myocardial conduction: a tool to investigate the role of gap junctional uncoupling in human arrhythmogenesis. J Am Coll Cardiol. 2006;48:1242-1249. (Pubitemid 44345136)
32. Wang D, Zhang F, Shen W, et al. Mesenchymal stem cell injection ameliorates the inducibility of ventricular arrhythmias after myocardial infarction in rats. Int J Cardiol. July 30, 2010 [Epub ahead of print].
33. Xie Y, Garfinkel A, Camelliti P, et al. Effects of fibroblast-myocyte coupling on cardiac conduction and vulnerability to reentry: a computational study. Heart Rhythm. 2009;6:1641-1649.
34. Rudy Y. Lessons learned about slow discontinuous conduction from models of impulse propagation. J Electrocardiol. 2005;38(Suppl): 52-54. (Pubitemid 41436487)
35. Poelzing S, Rosenbaum DS. Altered connexin43 expression produces arrhythmia substrate in heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H1762-H1770. (Pubitemid 39313284)
36. Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res. 1986;58:356-371. (Pubitemid 16120759)
37. Van Veen TA, Stein M, Royer A, et al. Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation. 2005; 112:1927-1935. (Pubitemid 41377410)
38. Kostin S, Rieger M, Dammer S, et al. Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol Cell Biochem. 2003;242:135-144. (Pubitemid 36240539)
39. Engelman ZJ, Trew ML, Smaill BH. Structural heterogeneity alone is a sufficient substrate for dynamic instability and altered restitution. Circ Arrhythm Electrophysiol. 2010;3:195-203.
40. Remme CA, Verkerk AO, Nuyens D, et al. Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation. 2006;114:2584-2594. (Pubitemid 44967341)
41. Coronel R, Casini S, Koopmann TT, et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. Circulation. 2005;112:2769-2777. (Pubitemid 41641670)
42. Frustaci A, Priori SG, Pieroni M, et al. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation. 2005; 112:3680-3687. (Pubitemid 43739507)
43. Jansen JA, van Veen AA, Bosch AA, et al. Arrhythmia vulnerability of aged haploinsufficient Cx43 mice is determined by heterogeneous downregulation of Cx43 combined with increased fibrosis. Circulation. 2008;118:S494.
44. Zhang Y, Kanter EM, Laing JG, et al. Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts. Cell Commun Adhes. 2008;15:289-303.
45. Ieda M, Tsuchihashi T, Ivey KN, et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell. 2009; 16:233-244.
46. Wilders R, Wagner MB, Golod DA, et al. Effects of anisotropy on the development of cardiac arrhythmias associated with focal activity. Pflugers Arch. 2000;441:301-312. (Pubitemid 32128171)
47. Pollard AE, Cascio WE, Fast VG, et al. Modulation of triggered activity by uncoupling in the ischemic border. A model study with phase 1b-like conditions. Cardiovasc Res. 2002;56:381-492.
48. De Groot JR, Wilms-Schopman FJ, Opthof T, et al. Late ventricular arrhythmias during acute regional ischemia in the isolated blood perfused pig heart. Role of electrical cellular coupling. Cardiovasc Res. 2001;50: 362-372. (Pubitemid 32382163)
49. Bogun F, Krishnan S, Siddiqui M, et al. Electrogram characteristics in postinfarction ventricular tachycardia: effect of infarct age. J Am Coll Cardiol. 2005;46:667-674. (Pubitemid 41132695)
50. Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43:2044-2053. (Pubitemid 38686799)
51. Berenfeld O, Zaitsev AV. The muscular network of the sheep right atrium and frequency-dependent breakdown of wave propagation. Anat Rec A Discov Mol Cell Evol Biol. 2004;280:1053-1061. (Pubitemid 39319331)
52. Zlochiver S, Yamazaki M, Kalifa J, et al. Rotor meandering contributes to irregularity in electrograms during atrial fibrillation. Heart Rhythm. 2008; 5:846-854.
53. Lin J, Scherlag BJ, Zhou J, et al. Autonomic mechanism to explain complex fractionated atrial electrograms (CFAE). J Cardiovasc Electrophysiol. 2007;18:1197-1205. (Pubitemid 47609881)
54. de Bakker JM, Wittkampf FH. The pathophysiologic basis of fractionated and complex electrograms and the impact of recording techniques on their detection and interpretation. Circ Arrhythm Electrophysiol. 2010;3:204-213.
55. Jacquemet V, Henriquez CS. Genesis of complex fractionated atrial electrograms in zones of slow conduction: a computer model of microfibrosis. Heart Rhythm. 2009;6:803-810.
56. Saumarez RC, Slade AK, Grace AA, et al. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation. 1995;91:2762-2768.
57. De Bakker JMT, van Capelle FJL, Janse MJ, et al. Slow conduction in the infarcted human heart;zigzag course of activation. Circulation. 1993;88: 915-926. (Pubitemid 23264006)
58. Fast VG, Kléber AG. Cardiac tissue geometry as a determinant of unidirectional conduction block: assessment of microscopic excitation spread by optical mapping in patterned cell cultures and in a computer model. Cardiovasc Res. 1995;29:697-707.
59. Rohr S, Kucera JP, Fast VG, et al. Paradoxical improvement of impulse conduction in cardiac tissue by partial cellular uncoupling. Science. 1997; 275:841-844. (Pubitemid 27074887)
60. Cabo C, Pertsov AM, Davidenko JM, et al. Vortex shedding as a precursor of turbulent electrical activity in cardiac muscle. Biophys J. 1996;70: 1105-1111. (Pubitemid 26073027)
61. Stein M, Boulaksil M, Jansen JA, et al. reduction of fibrosis related arrhythmias by chronic renin-angiotensin-aldosterone-system inhibitors in an aged mouse model. Am J Physiol Heart Circ Physiol. 2010;299: H310-H321.
62. De Mello WC. Beneficial effect of eplerenone on cardiac remodelling and electrical properties of the failing heart. J Renin Angiotensin Aldosterone Syst. 2006;7:40-46. (Pubitemid 43891244)
63. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation. 2000;102:1388-1393.
64. D́ez J, Querejeta R, López B, et al. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation. 2002;105: 2512-2517. (Pubitemid 34568973)
65. López B, Querejeta R, Varo N, et al. Usefulness of serum carboxyterminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients. Circulation. 2001;104:286-291. (Pubitemid 32666949)
66. Izawa H, Murohara T, Nagata K, et al. Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study. Circulation. 2005;112:2940-2945. (Pubitemid 41612295)
67. Zannad F, Alla F, Dousset B, et al. Limitation of excessive extracellular matrix turnovr may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). RALES Investigators. Circulation. 2000;102:2700-2706.
68. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341: 709-717. (Pubitemid 29407370)
69. Massare J, Berry JM, Luo X, et al. Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype. J Cardiovasc Electrophysiol. March 5, 2010 [Epub ahead of print].
70. Teraoka K, Hirano M, Ookubo H, et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging. 2004;22: 155-161. (Pubitemid 38326634)
71. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002. (Pubitemid 29529292)
72. Kwon DH, Setser RM, Popović ZB, et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study. Int J Cardiovasc Imaging. 2008;24:617-625.
73. Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation. 2007;115:2006-2014. (Pubitemid 46625951)
74. Fluechter S, Kuschyk J, Wolpert C, et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson. 2010;12:30.
75. Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561-1567. (Pubitemid 36543376)
76. Rubinstein R, Glockner JF, Ommen SR, et al. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail. 2010;3:51-58.
77. Ashikaga H, Sasano T, Dong J, et al. Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation. Circ Res. 2007;101:939-947. (Pubitemid 350287181)
78. Helm PA, Caravan P, French BA, et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. Radiology. 2008;247:788-796.